StockData
AtriCure, Inc. logo

AtriCure, Inc. (ATRC) stock

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30930% above fair value
$55.45+0.43 (+0.78%)

Close on Nov 18, 2026Market cap $2.82BP/E 264.0Yield –

AtriCure net income

Net income is the profit left for shareholders after every expense, interest and tax.

AtriCure's net income for the twelve months ending Jun 30, 2026 was $10.55M. For fiscal 2025 it was -$11.45M. The highest annual figure on record is $50.20M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.45M–
FY2024Dec 31, 2024-$44.70M–
FY2023Dec 31, 2023-$30.44M–
FY2022Dec 31, 2022-$46.47M-192.6%
FY2021Dec 31, 2021$50.20M–
FY2020Dec 31, 2020-$48.16M–
FY2019Dec 31, 2019-$35.19M–
FY2018Dec 31, 2018-$21.14M–
FY2017Dec 31, 2017-$26.89M–
FY2016Dec 31, 2016-$33.34M–
FY2015Dec 31, 2015-$27.21M–
FY2014Dec 31, 2014-$16.21M–
FY2013Dec 31, 2013-$11.46M–
FY2012Dec 31, 2012-$7.53M–
FY2011Dec 31, 2011-$5.46M–
FY2010Dec 31, 2010-$3.79M–
FY2009Dec 31, 2009-$16.49M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.96M–
Q1 FY2026Mar 31, 2026$108.00K–
Q4 FY2025Dec 31, 2025$1.76M–
Q3 FY2025Sep 30, 2025-$267.00K–
Q2 FY2025Jun 30, 2025-$6.19M–
Q1 FY2025Mar 31, 2025-$6.75M–
Q4 FY2024Dec 31, 2024-$15.57M–
Q3 FY2024Sep 30, 2024-$7.85M–
Q2 FY2024Jun 30, 2024-$8.01M–
Q1 FY2024Mar 31, 2024-$13.27M–
Q4 FY2023Dec 31, 2023-$9.79M–
Q3 FY2023Sep 30, 2023-$9.06M–
Q2 FY2023Jun 30, 2023-$5.12M–
Q1 FY2023Mar 31, 2023-$6.48M–
Q4 FY2022Dec 31, 2022-$4.17M–
Q3 FY2022Sep 30, 2022-$12.27M-112.6%
Q2 FY2022Jun 30, 2022-$14.84M–
Q1 FY2022Mar 31, 2022-$15.18M–
Q4 FY2021Dec 31, 2021-$13.74M–
Q3 FY2021Sep 30, 2021$97.11M–
Q2 FY2021Jun 30, 2021-$16.25M–
Q1 FY2021Mar 31, 2021-$16.92M–
Q4 FY2020Dec 31, 2020-$18.56M–
Q3 FY2020Sep 30, 2020-$4.95M–
Q2 FY2020Jun 30, 2020-$8.24M–
Q1 FY2020Mar 31, 2020-$16.41M–
Q4 FY2019Dec 31, 2019-$16.10M–
Q3 FY2019Sep 30, 2019-$9.36M–
Q2 FY2019Jun 30, 2019-$4.10M–
Q1 FY2019Mar 31, 2019-$5.64M–
Q4 FY2018Dec 31, 2018-$3.43M–
Q3 FY2018Sep 30, 2018-$7.24M–
Q2 FY2018Jun 30, 2018-$338.00K–
Q1 FY2018Mar 31, 2018-$10.13M–
Q4 FY2017Dec 31, 2017-$2.58M–
Q3 FY2017Sep 30, 2017-$7.25M–
Q2 FY2017Jun 30, 2017-$6.88M–
Q1 FY2017Mar 31, 2017-$10.18M–
Q4 FY2016Dec 31, 2016-$8.63M–
Q3 FY2016Sep 30, 2016-$6.78M–

More AtriCure figures

See a number that looks wrong?